Pancreatic Cancer Research

ResearcherHenan UniversityActive in the last 2 years

Bowei Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4936-2358; OpenAlex author ID A5024657790. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Comprehensive bioinformatics analysis of the prognostic value and immune infiltration of CAPN2 in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.gene.2024.149035↗
  2. Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells. First author DOI 10.2147/ott.s231153↗
  3. Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231. Co-author DOI 10.2147/ott.s259598↗
  4. Erratum: Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells [Corrigendum]. First author DOI 10.2147/ott.s259765↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuangyin Han · 3 shared papers, 2020 · strength 0.36
  2. Haoran Xie · 1 shared paper, 2025 · strength 0.25
  3. Qiuyan Zhao · 1 shared paper, 2025 · strength 0.25
  4. Bingyong Zhang · 1 shared paper, 2025 · strength 0.25
  5. Xiuling Li · 2 shared papers, 2020 · strength 0.24
  6. Wei Wang · 1 shared paper, 2020 · strength 0.12
  7. Zhaoshen Li · 1 shared paper, 2020 · strength 0.12
  8. Wei Ting Wang · 1 shared paper, 2020 · strength 0.12
  9. Zhao‐Shen Li · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.